SLC5A2 and familial dilated cardiomyopathy: Recently, it’s reported that another SGLT2 inhibitor empagliflozin ameliorates the microvascular injury of DCM by regulating AMPK signaling pathways to inhibit the mitochondrial fission (Zhou et al., 2018).